News
Kolon TissueGene participated in the 2025 Osteoarthritis Research Society International (OARSI) World Congress on ...
Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...
A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.
When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...
Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation or chemotherapy.
The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...
Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as ...
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...
A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...
New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...
The gene therapy nadofaragene firadenovec demonstrated strong clinical activity in Japanese patients with BCG-unresponsive ...
The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several patients with acute myeloid leukemia (AML), researchers said yesterday in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results